Stay updated on HER2/EGFR Mutant Tumors Clinical Trial

Sign up to get notified when there's something new on the HER2/EGFR Mutant Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HER2/EGFR Mutant Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer's revision tag was updated to v3.5.5, replacing the previous v3.5.4.
    Difference
    0.0%
    Check dated 2026-06-05T00:18:05.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page footer revision label has been updated from v3.5.3 to v3.5.4, indicating a minor version update.
    Difference
    0.0%
    Check dated 2026-05-21T15:51:03.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    A new revision entry, v3.5.3, was added to the study's history, replacing the previous v3.5.2. This updates the record history to reflect an additional iteration of the record.
    Difference
    0.0%
    Check dated 2026-04-30T02:43:24.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Updated the site revision indicator from **v3.5.0** to **v3.5.2**.
    Difference
    0.0%
    Check dated 2026-04-22T17:58:00.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Revision notes updated: added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-25T00:35:40.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added to the history, and the previous revision v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-10T14:36:22.000Z thumbnail image

Stay in the know with updates to HER2/EGFR Mutant Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HER2/EGFR Mutant Tumors Clinical Trial page.